French Patent Litigators
Team
Matthieu DHENNE
Benjamin MOLLET-VIEVILLE
Fields of expertise
Patents
Employee Inventions
Contracts
Trade Secrets
Saisie-contrefaçon
Pharmaceutical regulations
UPC
Blog
Contact
French Patent Litigators
Team
Matthieu DHENNE
Benjamin MOLLET-VIEVILLE
Fields of expertise
Patents
Employee Inventions
Contracts
Trade Secrets
Saisie-contrefaçon
Pharmaceutical regulations
UPC
Blog
Contact
Blog
21 February 2023
Trastuzumab x recombinant human hyaluronidase: the French Supreme Court clarifies the interpretation of article 1 b) of the SPC Regulation
Dhenne Avocats
13 February 2023
“Nivolumab and pembrolizumab cases”: the French Supreme Court clarifies the interpretation of Article 3 a) of the SPC Regulation
Dhenne Avocats
7 February 2023
“Thales” and “Bull” decisions: the French Supreme Court and the patentability of computer-implemented inventions
Dhenne Avocats
16 December 2022
Interview: French patent litigation
Dhenne Avocats
18 September 2022
OPPO’s New FRAND Order: “You got your injunction? Well, I quit” (French perspective)
Dhenne Avocats
5 September 2022
Moderna vs. Pfizer & BioNTech: French perspective
Dhenne Avocats
8 July 2022
French Judge Competent for Infringement Abroad: Private International Law vs. UPC?
Dhenne Avocats
4 July 2022
“AVELUMAB SPC Case”: A key U-turn in French case law
Dhenne Avocats
28 June 2022
A preliminary injunction can be based on a patent application (“fingolimod case”)
Dhenne Avocats
1
2
3
…
6
